Anderson KC - Search Results

1

Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.

Roccaro AM, Hideshima T, Raje N, Kumar S, Ishitsuka K, Yasui H, Shiraishi N, Ribatti D, Nico B, Vacca A, Dammacco F, Richardson PG, Anderson KC. Roccaro AM, et al. Among authors: anderson kc. Cancer Res. 2006 Jan 1;66(1):184-91. doi: 10.1158/0008-5472.CAN-05-1195. Cancer Res. 2006. PMID: 16397231

2

Functional interaction between retinoblastoma protein and stress-activated protein kinase in multiple myeloma cells.

Chauhan D, Hideshima T, Treon S, Teoh G, Raje N, Yoshihimito S, Tai YT, Li W, Fan J, DeCaprio J, Anderson KC. Chauhan D, et al. Among authors: anderson kc. Cancer Res. 1999 Mar 15;59(6):1192-5. Cancer Res. 1999. PMID: 10096546

3

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J, Anderson KC. Hideshima T, et al. Among authors: anderson kc. Cancer Res. 2001 Apr 1;61(7):3071-6. Cancer Res. 2001. PMID: 11306489

4

Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs.

Kumar S, Raje N, Hideshima T, Ishitsuka K, Roccaro A, Shiraishi N, Hamasaki M, Yasui H, Munshi NC, Richardson P, Figg WD, Anderson KC. Kumar S, et al. Among authors: anderson kc. Leukemia. 2005 Jul;19(7):1253-61. doi: 10.1038/sj.leu.2403776. Leukemia. 2005. PMID: 15858615

5

Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.

Raje N, Kumar S, Hideshima T, Ishitsuka K, Yasui H, Chhetri S, Vallet S, Vonescu E, Shiraishi N, Kiziltepe T, Elford HL, Munshi NC, Anderson KC. Raje N, et al. Among authors: anderson kc. Br J Haematol. 2006 Oct;135(1):52-61. doi: 10.1111/j.1365-2141.2006.06261.x. Epub 2006 Aug 22. Br J Haematol. 2006. PMID: 16925573 Free article.

6

A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.

Chauhan D, Velankar M, Brahmandam M, Hideshima T, Podar K, Richardson P, Schlossman R, Ghobrial I, Raje N, Munshi N, Anderson KC. Chauhan D, et al. Among authors: anderson kc. Oncogene. 2007 Apr 5;26(16):2374-80. doi: 10.1038/sj.onc.1210028. Epub 2006 Oct 2. Oncogene. 2007. PMID: 17016430

7

RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells.

Chauhan D, Hideshima T, Pandey P, Treon S, Teoh G, Raje N, Rosen S, Krett N, Husson H, Avraham S, Kharbanda S, Anderson KC. Chauhan D, et al. Among authors: anderson kc. Oncogene. 1999 Nov 18;18(48):6733-40. doi: 10.1038/sj.onc.1203082. Oncogene. 1999. PMID: 10597281

8

CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines.

Teoh G, Tai YT, Urashima M, Shirahama S, Matsuzaki M, Chauhan D, Treon SP, Raje N, Hideshima T, Shima Y, Anderson KC. Teoh G, et al. Among authors: anderson kc. Blood. 2000 Feb 1;95(3):1039-46. Blood. 2000. PMID: 10648420 Free article.

9

Isolation and characterization of human multiple myeloma cell enriched populations.

Tai YT, Teoh G, Shima Y, Chauhan D, Treon SP, Raje N, Hideshima T, Davies FE, Anderson KC. Tai YT, et al. Among authors: anderson kc. J Immunol Methods. 2000 Feb 21;235(1-2):11-9. doi: 10.1016/s0022-1759(99)00199-4. J Immunol Methods. 2000. PMID: 10675753

10

Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.

Hideshima T, Chauhan D, Teoh G, Raje N, Treon SP, Tai YT, Shima Y, Anderson KC. Hideshima T, et al. Among authors: anderson kc. Clin Cancer Res. 2000 Mar;6(3):1180-9. Clin Cancer Res. 2000. PMID: 10741750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,229 results

Search Page

Filters